Ginsenosides from Panax ginseng as potential therapeutic candidates for the treatment of inflammatory bowel disease.

Inflammatory bowel disease (IBD) is characterized by a chronic inflammation of the intestine, which significantly affects patients' quality of life. As a perennial plant with the homology of medicine and food, Panax ginseng is known for its substantial anti-inflammatory effects in various inflammatory disorders. Ginsenosides, the main bioactive compounds of P. ginseng, are recognized for their efficacy in ameliorating inflammation. Over the past decade, approximately 150 studies have investigated the effects of P. ginseng and ginsenosides on IBD treatment and new issues have arisen. However, there has yet to be a comprehensive review assessing the potential roles of ginsenosides in IBD therapy. This manuscript strictly adheres to the PRISMA guidelines, thereby guaranteeing systematic synthesis of data. The research articles referenced were sourced from major scientific databases, including Google Scholar, PubMed, and Web of Science. The search strategy employed keywords such as "ginsenoside", "IBD", "colitis", "UC", "inflammation", "gut microbiota", and "intestinal barrier". For image creation, Figdraw 2.0 was methodically employed. Treatment with various ginsenosides markedly alleviated clinical IBD symptoms. These compounds have been observed to restore intestinal epithelia, modulate cellular immunity, regulate gut microbiota, and suppress inflammatory signaling pathways. An increasing body of research supports the potential of ginsenosides in treating IBD. Ginsenosides have emerged as promising therapeutic agents for IBD, attributed to their remarkable efficacy, safety, and absence of side effects. Nevertheless, their limited bioavailability presents a substantial challenge. Thus, efforts to enhance the bioavailability of ginsenosides represent a crucial and promising direction for future IBD research. Copyright © 2024 Elsevier GmbH. All rights reserved.

Citation

Zhiqiang Niu, Yanan Liu, Ruyi Shen, Xiaojian Jiang, Yanting Wang, Ziliang He, Junyao Li, Yeye Hu, Ji Zhang, Yunyao Jiang, Weicheng Hu, Chuanling Si, Shuai Wei, Ting Shen. Ginsenosides from Panax ginseng as potential therapeutic candidates for the treatment of inflammatory bowel disease. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024 May;127:155474

Mesh Tags

Substances

PMID: 38471369

search → result